Bluejay Diagnostics, Inc. and Blood Centers of America (BCA) announced that they have executed a collaborative agreement to develop commercial relationships to serve unmet needs by utilizing the Symphony(TM) Platform in the blood and hospital markets. As part of the agreement, Bluejay will be recognized as a strategic partner of BCA member organizations, with BCA referring strategic group purchasing organization (GPO) partners and BCA's member blood centers to Bluejay. Bluejay gains access to BCA members and their network to offer them Bluejay's innovative solutions.

The collaboration also provides opportunities to support clinical studies and explore direct applications for Symphony in the blood supply industry.